Scarica l'app Stockscreener
23.69
0.34%
0.08
Dopo l'orario di chiusura:
23.69
Precedente Chiudi:
$23.61
Aprire:
$24.18
Volume 24 ore:
305.32K
Relative Volume:
0.81
Capitalizzazione di mercato:
$909.18M
Reddito:
$95.07M
Utile/perdita netta:
$-60.37M
Rapporto P/E:
-14.54
EPS:
-1.6291
Flusso di cassa netto:
$-50.92M
1 W Prestazione:
+0.00%
1M Prestazione:
-4.51%
6M Prestazione:
+27.57%
1 anno Prestazione:
+100.59%
Intervallo 1D:
$23.32
$24.19
Intervallo di 1 settimana:
$23.32
$25.25
Portata 52W:
$10.85
$25.63
Ceribell Inc Stock (CBLL) Company Profile
Nome
Ceribell Inc
Settore
Industria
Telefono
(800) 436-0826
Indirizzo
360 N. PASTORIA AVENUE, SUNNYVALE
Compare CBLL vs ABT, MDT, SYK, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CBLL
Ceribell Inc
|
23.69 | 909.18M | 95.07M | -60.37M | -50.92M | -1.6291 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ceribell Inc Stock (CBLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-21 | Iniziato | Raymond James | Strong Buy |
| 2025-06-24 | Iniziato | BTIG Research | Buy |
| 2025-04-04 | Iniziato | Ladenburg Thalmann | Buy |
| 2024-11-05 | Iniziato | BofA Securities | Buy |
| 2024-11-05 | Iniziato | Canaccord Genuity | Buy |
| 2024-11-05 | Iniziato | JP Morgan | Overweight |
| 2024-11-05 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Iniziato | William Blair | Outperform |
Mostra tutto
Ceribell Inc Borsa (CBLL) Ultime notizie
Form 144 Ceribell For: 1 October By Investing.com - Investing.com Canada
Ceribell Officer Raymond Woo Files Form 144 for Proposed Sale of 4,887 Shares - Kalkine Media
CeriBell: FDA Clearances And Delirium Expansion Could Create A New Growth Driver - Seeking Alpha
Ceribell receives FDA clearance for new EEG software features - Investing.com
Ceribell receives FDA clearance for new EEG software features By Investing.com - Investing.com South Africa
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG Analysis - GlobeNewswire
Ceribell stock price target reiterated at $30 by BTIG on growth outlook - Investing.com Nigeria
BTIG Maintains Ceribell(CBLL.US) With Buy Rating, Maintains Target Price $30 - Moomoo
Blumberg Scott Executes 846 Ceribell Options and Disposes Shares on September 15, 2026 - Kalkine Media
CeriBell, Inc. (CBLL) Stock Analysis: Exploring the 12% Potential Upside in the Innovative Medical Device Sector - DirectorsTalk Interviews
Ceribell CFO Scott Blumberg exercises options, sells $21,150 in stock. - Investing.com India
Ceribell president and CEO Chao Xingjuan sells $521,775 in stock By Investing.com - Investing.com Nigeria
Ceribell president and CEO Chao Xingjuan sells $521,775 in stock - Investing.com
Ceribell CFO Scott Blumberg exercises options, sells $21,150 in stock. By Investing.com - Investing.com Canada
Ceribell (CBLL) CEO sells stock under a preset 2025 trading plan - Stock Titan
Ceribell (CBLL) CFO sells 846 shares under 10b5-1 plan - stocktitan.net
Ceribell: Q2 Revenue Growth, FDA Clearances And NTAP Reimbursement In Focus - RTTNews
CeriBell, Inc.Common Stock (CBLL) Stock Price, News, Quote & History - FinancialContent
Ceribell CTO Raymond Woo sells $118,900 of company stock By Investing.com - Investing.com South Africa
BTIG reiterates Ceribell stock rating at buy, $30 price target By Investing.com - Investing.com South Africa
BTIG reiterates Ceribell stock rating at buy, $30 price target - Investing.com India
Ceribell senior VP sells $224,451 of company stock - Investing.com India
Ceribell senior VP sells $224,451 of company stock By Investing.com - Investing.com South Africa
Ceribell CTO Raymond Woo sells $118,900 of company stock - Investing.com
Ceribell (CBLL) CTO trades stock under Rule 10b5-1 plan - stocktitan.net
Ceribell CEO Chao Xingjuan Executes Options and Sells 39,540 Shares at $24.61, Retains 767,191 Shares - Kalkine Media
Ceribell | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo
Electroencephalography Devices Market (2033): Tabletop EEG, - openPR.com
Ceribell CEO Chao Xingjuan sells $973,079 in company stock By Investing.com - Investing.com South Africa
Ceribell CFO Scott Blumberg sells $16,300 in common stock By Investing.com - Investing.com India
Ceribell CFO Scott Blumberg sells $16,300 in common stock - investing.com
Ceribell CEO Chao Xingjuan sells $973,079 in company stock - investing.com
Ceribell (CBLL) CEO sells nearly 40,000 shares under plan - stocktitan.net
CFO at Ceribell (CBLL) sells 652 shares under preset plan - Stock Titan
William Blair Maintains Ceribell(CBLL.US) With Buy Rating - Moomoo
Ceribell, Inc. (CBLL) Gets a Buy from Raymond James - The Globe and Mail
Raymond James raises Ceribell stock price target on new growth drivers - Investing.com Australia
Insiders At CeriBell Sold US$1.0m In Stock, Alluding To Potential Weakness - Moomoo
Ceribell (CBLL) CRO Joseph Manni sells $32,691 in shares By Investing.com - Investing.com India
Ceribell CFO Blumberg sells $36,534 in stock By Investing.com - Investing.com Nigeria
Ceribell CTO Raymond Woo sells $47,535 in company stock By Investing.com - Investing.com Nigeria
Ceribell president and CEO Chao Xingjuan sells $145,753 in stock By Investing.com - Investing.com Nigeria
Ceribell senior VP Foehr sells $44,424 in company stock By Investing.com - Investing.com Australia
Ceribell Inc Azioni (CBLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ceribell Inc Azioni (CBLL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chao Xingjuan | President and CEO |
Sep 15 '26 |
Sale |
25.03 |
20,846 |
521,775 |
746,345 |
| Blumberg Scott | Chief Financial Officer |
Sep 15 '26 |
Option Exercise |
9.41 |
846 |
7,961 |
147,446 |
| Blumberg Scott | Chief Financial Officer |
Sep 15 '26 |
Sale |
25.00 |
846 |
21,150 |
146,600 |
0.26%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):